A Plasmodium falciparum copper-binding membrane protein with copper transport motifs by David L Choveaux et al.
Choveaux et al. Malaria Journal 2012, 11:397
http://www.malariajournal.com/content/11/1/397RESEARCH Open AccessA Plasmodium falciparum copper-binding
membrane protein with copper transport motifs
David L Choveaux1, Jude M Przyborski2 and JP Dean Goldring1*Abstract
Background: Copper is an essential catalytic co-factor for metabolically important cellular enzymes, such as
cytochrome-c oxidase. Eukaryotic cells acquire copper through a copper transport protein and distribute
intracellular copper using molecular chaperones. The copper chelator, neocuproine, inhibits Plasmodium falciparum
ring-to-trophozoite transition in vitro, indicating a copper requirement for malaria parasite development. How the
malaria parasite acquires or secretes copper still remains to be fully elucidated.
Methods: PlasmoDB was searched for sequences corresponding to candidate P. falciparum copper-requiring
proteins. The amino terminal domain of a putative P. falciparum copper transport protein was cloned and
expressed as a maltose binding fusion protein. The copper binding ability of this protein was examined. Copper
transport protein-specific anti-peptide antibodies were generated in chickens and used to establish native protein
localization in P. falciparum parasites by immunofluorescence microscopy.
Results: Six P. falciparum copper-requiring protein orthologs and a candidate P. falciparum copper transport protein
(PF14_0369), containing characteristic copper transport protein features, were identified in PlasmoDB. The
recombinant amino terminal domain of the transport protein bound reduced copper in vitro and within Escherichia
coli cells during recombinant expression. Immunolocalization studies tracked the copper binding protein
translocating from the erythrocyte plasma membrane in early ring stage to a parasite membrane as the parasites
developed to schizonts. The protein appears to be a PEXEL-negative membrane protein.
Conclusion: Plasmodium falciparum parasites express a native protein with copper transporter characteristics that
binds copper in vitro. Localization of the protein to the erythrocyte and parasite plasma membranes could provide
a mechanism for the delivery of novel anti-malarial compounds.
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Malaria is a serious, acute and chronic relapsing infec-
tion that kills close to one million people annually. More
than 90% of these deaths are recorded in the sub-
Saharan regions of Africa, with the majority being chil-
dren under the age of five years [1]. Human mortality, as
a result of malaria infection, is predominantly caused by
Plasmodium falciparum. Efforts to prevent and control
the disease have, however, been hindered by an increased
parasite resistance to currently available anti-malarial
drugs, highlighting the need for novel anti-malarial drug
development [2]. A group of proteins gaining increased* Correspondence: goldringd@ukzn.ac.za
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reproduction in any medium, provided the orinterest as potential therapeutic targets are the integral
membrane proteins predicted to possess transport func-
tions [3,4]. Despite these proteins playing key roles in
Plasmodium parasite growth and replication [4], they re-
main poorly understood and underexploited [3]. Previous
studies employing the intracellular copper chelator neocu-
proine established that copper is an essential micronu-
trient for in vitro parasite growth [5]. Rasoloson et al. [5]
described the membrane-bound PfCuP-ATPase copper ef-
flux protein and suggested this protein acts to reduce cop-
per toxicity in P. falciparum. Studying P. falciparum
copper metabolism may lead to the identification of novel
anti-malarial drug targets.
Copper is an essential micronutrient that plays import-
ant catalytic and structural roles in numerous enzymes.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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between a stable oxidized Cu(II) and unstable reduced
Cu(I) state for various redox reactions. However, this
property also makes copper potentially toxic to cells
since it can undergo free radical producing Fenton
chemistry [6]. Consequently, cells have evolved homeo-
static mechanisms for the uptake, distribution, sequestra-
tion and secretion of copper to meet essential cellular
requirements while reducing its toxic potential. From
yeast to humans, copper acquisition is mediated by the
high affinity copper transport protein, Ctr1 [7,8]. Copper
metallochaperones subsequently distribute intracellular
copper to specific proteins or organelles. The copper
chaperone for superoxide dismutase (CCS) distributes
copper to cuprozinc superoxide dismutase (Cu/Zn SOD)
in the cytosol and mitochondrion, antioxidant protein 1
(Atox1) transfers copper to the secretory pathway and
nucleus and an ensemble of proteins deliver copper to
cytochrome-c oxidase (CCO) in the mitochondrion [7,8].
It has been suggested that Cu-ATPase-mediated secre-
tion of excess copper is the main factor regulating copper
homeostasis [9]. Equally important to mammalian
growth and development, however, is the copper trans-
porter Ctr1. Cell-specific knock-out of Ctr1 in mouse
intestinal epithelial cells caused marked growth retard-
ation, coupled with cardiac hypertrophy and overall
viability defects that caused postnatal lethality around
three weeks of age [10]. Similarly, knock-out of the
Drosophila melanogaster Ctr1A gene resulted in develop-
mental arrest at early larval stages [11]. The C terminus
of yeast copper transport protein, Ctr1, appears to have a
role in copper regulation and stopping the build-up of
copper to toxic concentrations [12].Table 1 Copper-dependent protein orthologs to Homo sapien
Enzyme name Accession number P
CCS CAG46726









Cytochrome-c oxidase subunit I ACR77861
Cytochrome-c oxidase subunit II ABU47824
Cytochrome-c oxidase subunit III ABJ99455
Cytochrome-c oxidase subunit Vb AAA52060
Cytochrome-c oxidase subunit VIb AAP35591Although a P. falciparum P-type ATPase copper efflux
protein has been described [5], an additional protein-
mediated mechanism for copper acquisition has not.
The current study describes a novel membrane-bound
P. falciparum protein with copper transporter character-
istics. A recombinant form of the protein's amino ter-
minal region bound reduced copper in vitro and within
E. coli host cells. The native P. falciparum copper trans-
port protein was found to initially localize to the infected
erythrocyte membrane, followed by relocation to a para-




The annotated Plasmodium database [13] was screened
for the presence of copper-requiring protein orthologs
using a BlastP search. Sequences used to screen the
database are listed in Table 1. A putative Plasmodium
copper transport protein was identified using the Theileria
parva (Muguga stock) polymorphic immunodominant
molecule (GenBank:AAA99499) [14] to BlastP screen
PlasmoDB. In an effort to support sequence identity, the
putative Plasmodium copper transport protein sequences
were aligned with characterized copper transporter
sequences from Homo sapiens (NCBI:NP_001850), Arabi-
dopsis thaliana (Genbank:BAE98928) and Saccharomyces
cerevisiae (Genbank:AAB68064) using the ClustalWTM
server. Transmembrane domains were identified in the
putative Plasmodium copper transporters using the
HMMTOP [15] and TMHMM 2.0 [16] topology pre-
diction servers. The presence of potential signal
sequences in each protein was established using thes proteins identified in the P. falciparum proteome
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for Biological Sequence Analysis, Lyngby, Denmark). A
cladogram was generated from a ClustalW™ alignment
of six putative Plasmodium copper transporters with
seven characterized copper transporters. The charac-
terized transporters were from Homo sapiens, Mus
musculus (NCBI:NP_780299), Rattus norvegicus
(NCBI:NP_598284), Danio rerio (NCBI:NP_991280),
Arabidopsis thaliana, Saccharomyces cerevisiae and
Theileria parva.Antibody production and purification
The amino acid sequence for a putative P. falciparum
copper transport protein (PF14_0369) was retrieved
from PlasmoDB and subjected to Predict7 [17] analysis
to identify immunogenic regions and the peptide
CNLQKEEDTVVQLQD was selected for synthesis (GL
Biochem Ltd. Shanghai, China). The selected peptide
was coupled to rabbit albumin via the native amino
terminal cysteine residue using m-maleimidobenzoyl-
N-hydroxysuccinimide ester. Hy-Line Brown hens
were used for antibody generation and antibodies were
isolated from egg yolk as previously described [18,19].
Animal ethics clearance was obtained from the University
of KwaZulu-Natal animal ethics committee (003/10/
Animal).PCR amplification and cloning
Plasmodium falciparum (D10) gDNA was isolated from
infected red blood cells using the FermentasTM DNA
purification kit. The full-length PF14_0369, open reading
frame was amplified using the following specific primers:
PfCtr369-fwd: 5'-atGAATTCGACAAAAGCGACAATA
GTATTTG-3' and PfCtr369FL-rev: 5'-ACATCCACAA
CAAGCTGGATC. For functional copper binding stud-
ies, the coding domain for the protein's amino terminal
domain minus signal peptide was amplified using the
PfCtr369-fwd primer containing an engineered EcoRI
cleavage site and PfCtr369Nt-rev: 5'-caCTGCAGTTAC
GATTTGGTTTCCCATTTG-3' containing a PstI clea-
vage site (cleavage sites underlined). PCR products were
analyzed on a 1% (w/v) agarose gel. The PCR amplicon
for the PF14_0369 amino terminal domain (designated
Nt) minus signal peptide (PfCtr369Nt-S) was cloned in
frame with the maltose binding protein (MBP) gene in
the pMal-p2x bacterial expression vector (New England
BioLabs, USA), as previously described [18].The integrity
of the resultant pMal-p2x/PfCtr369Nt-S plasmid insert
was confirmed by DNA sequencing. Using the strategy
employed for pMal-p2x/PfCtr369Nt-S, a plasmid con-
taining pMal-p2X/PfCtr211Nt-S from the PF14_0211
gene was prepared.Expression and purification of recombinant
MBP-PfCtr369Nt-S
A single E. coli JM103[pMal-p2x/PfCtr369Nt-S] colony
was grown overnight at 30°C in sterile LB medium sup-
plemented with 100 μg.ml-1 ampicillin. The overnight
culture was diluted in fresh broth, plus antibiotic, and
incubated at 30°C until the A600 reached ~0.6. MBP-
PfCtr369Nt-S expression was induced with 0.3 mM IPTG
and the cultures grown for a further 16 h before harvest-
ing of cells by centrifugation (4000 g, 15 min, 4°C). The
E. coli periplasmic content was isolated following the
method described by French et al. [20] and the recom-
binant protein purified by amylose affinity chromatog-
raphy. Recombinant MBP-PfCtr211Nt-S was expressed
using the same procedure. Protein samples were analyzed
on a 12.5% SDS-PAGE gel [21] followed by Western blot-
ting and probed with chicken anti-PF14_0369 and anti-
MBP antibodies [22] (see below). Protein concentration
was determined with the Bradford dye-binding protein
assay, using ovalbumin as the standard [23].
Parasite culture
Plasmodium falciparum 3D7 parasites were cultured in
human O+ erythrocytes according to standard protocols,
except cultures were incubated in gassed flasks [24].
Synchronized asexual parasites were obtained by sorbitol
treatment [25].
Western blot analyses
For Western blot analyses of P. falciparum lysates, pro-
tein samples were prepared from saponin-isolated,
sorbitol-synchronized parasites. Equivalent amounts of
1 x 107 parasites were analysed by 12.5% SDS-PAGE
and transferred to a nitrocellulose membrane. Primary
chicken anti-PF14_0369 and chicken anti-P. falciparum
lactate dehydrogenase (LDH) antibodies against spe-
cific peptides on each protein were employed and
detected using rabbit anti-chicken horseradish peroxidase-
conjugated secondary antibodies (DAKO, Santa Cruz).
Immunoblots were developed using enhanced chemilu-
minescence. Recombinant MBP-PfCtr369Nt-S expression
was analysed by Western blot using chicken anti-MBP
and anti-PF14_0369 anti-peptide antibodies. These anti-
bodies were detected using rabbit anti-chicken horsera-
dish peroxidase-conjugated secondary antibodies (Jackson
Immuno-Research Laboratories, USA) and visualized by
incubating the membrane in 0.06% (w/v) 4-chloro-1-
naphthol and 0.0015% (v/v) H2O2.
Copper binding
For in vitro copper binding studies, purified MBP-
PfCtr369Nt-S (10 μM) was mixed with 200 μM CuCl2,
with or without 10 mM ascorbic acid, and incubated at
RT for 15 min. Unbound copper was removed by
Choveaux et al. Malaria Journal 2012, 11:397 Page 4 of 15
http://www.malariajournal.com/content/11/1/397overnight dialysis against sodium phosphate buffer
[0.1 M NaH2PO4, 0.01% (w/v) NaN3, pH 7.5] at 4°C.
Copper binding to MBP-PfCtr369Nt-S and the oxidation
state of bound copper was assessed using the bicincho-
ninic acid (BCA) assay [26], in which protein-copper
complexes are disrupted by acid denaturation and cop-
per detected upon release. BCA binds reduced copper
(Cu+), forming a purple complex detectable at 354 nm.
If copper is present in solution as Cu2+, ascorbate must
be added to the sample following acid denaturation to
yield a Cu+-BCA complex. However, if the addition of
ascorbate does not influence Cu+-BCA complex forma-
tion, this indicates copper was released from the protein
in the Cu+ state. Solutions of CuCl2 in sodium phos-
phate buffer were used as standards and affinity purified
MBP served as a negative control. The ability of MBP-
PfCtr369Nt-S to bind copper within E. coli cells was also
examined. Cells containing the recombinant protein were
grown in the presence or absence of 0.5 mM CuCl2, and
the recombinant protein purified as described above.
Prior to cell disruption and MBP-PfCtr369Nt-S isolation,
pelleted cells were washed with a Tris buffer (0.2 M
Tris–HCl, pH 7.5) to remove extraneous CuCl2. As with
in vitro copper binding, copper bound to MBP-
PfCtr369Nt-S within E. coli cells was detected using the
BCA assay.Ascorbate oxidation assay
The ability of MBP-PfCtr369Nt-S to inhibit the copper-
catalysed oxidation of ascorbic acid (H2Asc) was tested
in vitro. In a typical experiment a mixture was prepared
containing 5 μM MBP-PfCtr369Nt-S,, or 5 μM MBP
(control), 8 μM CuCl2 and 120 μM H2Asc solution,
adjusted to pH 4.5 with NaOH. The absorbance of this
solution was monitored at 255 nm with readings taken
every 5 s for 300 s. Reactions were carried out at RT.Immunofluorescence
Immunofluorescence assays were carried out following
cell fixation with 4% paraformaldehyde/0.00075% (w/v)
glutaraldehyde as previously described [27] except fixa-
tion was carried out at 37°C for 30 minutes and quench-
ing was performed with 125 mM glycine/PBS. Chicken
anti-peptide antibodies directed against P. falciparum
lactate dehydrogenase and PF14_0369 and a rabbit anti-
body against Exp-1 were used. Primary antibodies were
diluted in 3% (w/v) BSA/PBS and detected with either
goat anti-chicken-Cy3 or goat anti-rabbit-Cy2 antibodies
(DAKO, Santa Cruz). Hoechst 33258 (Molecular probes)
was used at a concentration of 50 ng.ml-1 to stain parasite
DNA. All images were acquired at room temperature on a
Zeiss Cell Observer using appropriate filter sets.Results
Identification of copper-dependent protein orthologs in
the P. falciparum proteome
Cytochrome-c oxidase (CCO) is a key multi-subunit
catabolic protein containing three functionally important
copper ions in its binuclear CuA and mononuclear CuB
sites [28]. Metallation of the CuA and CuB sites requires
the copper metallochaperones Cox17, Sco1 and Cox11
[29]. Identification of P. falciparum orthologs of these
metallochaperones and other related copper-requiring
proteins supports a plasmodial requirement for copper,
as previously suggested [5]. A BlastP search of Plas-
moDB, using mammalian and yeast proteins, identified
six copper binding protein orthologs (Table 1). These
were Cox11, Cox17, Cox19, Sco1, five CCO subunits
and S-adenosyl-L-homocysteine hydrolase. The identifi-
cation of CCO subunit I and II orthologs appears most
important since these house the binuclear CuA and
mononuclear CuB copper binding sites [28]. Interest-
ingly, the P. falciparum proteome appears to lack an
identifiable class of metallothioneins and Cu/Zn SOD
(Table 1). In yeast and mammalian cells, these proteins
are essential for copper storage and free radical detoxifi-
cation, respectively [7,8].
Identification of a putative Plasmodium copper transport
protein
Although P. falciparum appears to require copper for
survival [5], the mechanism by which the parasite
acquires copper remains to be formally identified. One
suggested mechanism is acquisition via the ingestion
and digestion of host erythrocyte Cu/Zn SOD [5]. A po-
tential alternate mechanism is acquisition via a copper
transport protein. The Theileria parva polymorphic
immunodominant molecule sequence [14], which pos-
sesses copper transport protein features, was used to
screen PlasmoDB for a candidate Plasmodium copper
transport protein. Full length, putative copper trans-
porter sequences were identified for six Plasmodium
species, namely Plasmodium falciparum (PF14_0369
and PF14_0211), Plasmodium vivax (PVX_118540),
Plasmodium yoelIi (PY00413), Plasmodium berghei
(PBANKA_130290), Plasmodium chabaudi (PCHAS_
130610), and Plasmodium knowlesi (PKH_126730). In-
complete sequences possessing copper transporter features
were identified for Plasmodium gallinaceum (Pgal0564e04)
and Plasmodium reichenowi (reich164f12.q1k). Analysis of
the complete Plasmodium sequences with HMMTOP [15]
and TMHMM [16] identified at least three putative trans-
membrane domains and a signal peptide in the sequences
(Figure 1A). The Plasmodium copper transport protein
sequences contain characteristic features of the copper
transport protein family, including three transmembrane


















Figure 1 Features characteristic of the copper transport protein family are conserved in the putative Plasmodium copper transporters.
A. Three transmembrane (1–3), an extracellular amino terminal (Nt) and intracellular carboxy terminal (Ct) domains, methionine and MxxxM and
GxxxG motifs of copper transport proteins. B. An aligned region of the Plasmodium and other copper transporters showing the MxxxM and
GxxxG motifs. Sequence identifiers are: Hs = Homo sapiens; Ms =Mus musculus; Tp = Theileria parva; Cp = Cryptosporidium parvum; Pf = P.
falciparum PF14_0369; Pv = P. vivax; Py = P. yoelii; Pb = P. berghei; Pc = P. chabaudi; Pg = P. gallinaceum; Pk = P. knowlesi; Pr = P. reichenowi.
Underlined amino acids (Hs) indicate the positions of transmembrane domains two and three. C. Cladogram comparing six complete Plasmodium
copper transporter sequences with seven characterized transporters from various organisms. D. PCR amplification of the PF14_0369 coding
domain from P. falciparum gDNA. Lane 1, full-length PF14_0369 coding domain; lane 2, amino terminal domain of PF14_0369; lane 3, P.
falciparum LDH (PF13_0141) control. A Fermentas DNA ladder (M) is shown to the left of the gel.
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essential MxxxM (Mx3M) and GxxxG (Gx3G) motifs
(Figure 1B) in the second and third transmembrane
domains respectively. An essential methionine residue,
located 20 amino acid residues from the first putative trans-
membrane domain [30], is present in all the Plasmodium
sequences (Additional file 1).
A cladogram was generated for the complete Plasmo-
dium copper transporters to compare their similarity to
seven characterized copper transporters. The Plasmodium
copper transporters formed a cluster related to, but separate
from, the characterized copper transporters (Figure 1C). Of
the characterized transporters, the sequence with the great-
est similarity to that of Plasmodium parasites was from
Theileria parva. This was to be expected since T. parva
belongs to the same phylum as Plasmodium parasites, the
Apicomplexans [31]. Closer analysis of the Plasmodium
sequences indicated that the three rodent-infecting malaria
parasites cluster together, whilst P. vivax, P. knowlesi and
P. falciparum form a separate but related cluster. Similar
relationships have been observed from a phylogenetic
analysis of the Plasmodium cytochrome-b and small sub-
unit rRNA sequences [32]. The separate cluster of the
mammalian, yeast and plant reference sequences suggests
a more distant similarity to the Plasmodium sequences.Considering its clinical importance, P. falciparum was
selected for further studies of the putative copper trans-
porter. The gene encoding the putative copper transport
protein (PF14_0369) is located on the positive strand of
chromosome 14 as a two-exon gene with a 336 bp first
exon and 372 bp second exon, translating to a 235
amino acid protein with a predicted mass of 27.15 kDa.
The full length and amino terminal coding domain co-
ding sequences for the putative P. falciparum copper
transport protein (PF14_0369) were PCR amplified from
genomic DNA, producing amplicons of approximately
890 bp and 290 bp, respectively (Figure 1D). An 820 bp
product was amplified for the LDH control (Figure 1D).
The identity of the amplicon for the putative transpor-
ter’s amino terminal domain (PfCtr369Nt-S) was con-
firmed by sequencing. This amplicon was cloned and
expressed as a MBP fusion partner (MBP-PfCtr369Nt-S).
Recombinant expression of MBP-PfCtr369Nt-S
The amino terminal domain of yeast and mammalian
copper transport proteins is essential for copper acquisi-
tion [33], hence the corresponding domain of the puta-
tive P. falciparum copper transporter was selected for
copper binding studies. A similar approach has been
adopted for characterization of the PfCuP-ATPase
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combinant MBP-PfCtr369Nt-S associating with a bacte-
rial membrane, the predicted signal peptide was omitted
and denoted as “-S” [34]. Expression of a 55 kDa protein
was induced from the MBP-PfCtr369Nt-S plasmid and
affinity purified from the bacterial periplasmic contents
using an amylose affinity matrix (Figure 2A). The size of
the purified protein corresponded well with that pre-
dicted from the cloned sequence (54 kDa). An additional
42 kDa product, in the purified MBP-PfCtr369Nt-S frac-
tion, is likely to be MBP lacking the fused protein. A
Western blot using anti-MBP antibodies recognizes both
the 42 kDa and 55 kDa bands (Figure 2B), whilst anti-
bodies specific for PfCtr369Nt-S only recognize the
55 kDa band (Figure 2C). Also evident in the anti-MBP
(Figure 2B) and anti-PfCtr369Nt-S blots (Figure 2C) are
additional truncated forms of MBP-PfCtr369Nt-S be-
tween the 55 kDa and 42 kDa bands. Recombinant
MBP-PfCtr211Nt-S was expressed as a 46 kDa protein
(Additional file 2).
MBP-PfCtr369Nt-S binds copper
In yeast and mammalian cells, copper appears to be
transported across the membrane in its reduced form
(Cu+) [30] and hence a Cu+ preference was examined for
the putative P. falciparum copper transporter. Purified
MBP-PfCtr369Nt-S was incubated with CuCl2 in the
presence or absence of the reducing agent ascorbate.
Unbound copper was removed by dialysis and the bound
copper detected using the BCA assay [26] with or with-
out a second treatment of ascorbate. If ascorbate was
required in the BCA assay for the formation of a purple
complex it suggests Cu2+ is preferentially bound. Alter-
natively, if ascorbate supplementation was not required
for colour formation then Cu+ is suggested to be the
preferred substrate. Purified MBP-PfCtr369Nt-S showed
a binding preference for Cu+ in vitro (Figure 3A). Exclu-
sion of ascorbate from the initial CuCl2 incubationFigure 2 Expression and purification of recombinant MBP-PfCtr369Nt
A. Steps in the isolation of recombinant MBP-PfCtr369Nt-S were analysed o
anti-MBP B. or anti-PF14_0369 antibodies C. In all panels: lane 1, total E. co
proteins that did not bind, were washed from and eluted off the amylose
each image.resulted in low levels of detectable copper (Figure 3A),
whereas including ascorbate resulted in a ~70% increase
(p < 0.01) in the amount of copper detected. The absence
of ascorbate from the BCA assay did not affect BCA-Cu+
complex formation for the sample originally incubated
with ascorbate, thereby supporting a preference for Cu+
(Figure 3A).
The ability of MBP-PfCtr369Nt-S to bind copper
within a cellular environment was examined by expres-
sing the protein in the presence of 0.5 mM CuCl2. This
concentration of copper does not affect E. coli growth
[35]. MBP-PfCtr369Nt-S isolated and affinity purified
from E. coli cells grown in copper-enriched media,
bound copper (Figure 3B). Extraneous copper was
removed by washing the cells prior to protein isolation.
Protein isolated from cells grown without copper had
negligible amounts of copper present (p < 0.01)
(Figure 3B). The oxidation state of copper bound within
the cell was inferred by including or excluding ascorbate
from the BCA assay (Figure 3B). Like the in vitro ana-
lysis, Cu+ appeared to be the preferred oxidation state
bound by the protein within the E. coli periplasm. An
interesting consequence when copper was added to the
E. coli growth medium was a four-fold increase in MBP-
PfCtr369Nt-S yield from 1.53 mg to 5.98 mg per litre of
culture (p < 0.01) (Figure 3B, inset). In all experiments
MBP served as a negative control. Recombinant MBP
did not bind copper and CuCl2 had no perceptible in-
fluence on MBP expression (Figure 3).
Analysis of copper binding to MBP-PfCtr369Nt-S using the
rate of ascorbate oxidation
By taking advantage of the copper-catalysed oxidation
rate of ascorbate and the ability of chelators to affect
this rate, Jiang et al. [36] demonstrated that copper
transport protein methionine motif peptides bind Cu+
with methionine-only coordination. The effect MBP-
PfCtr369Nt-S had on copper-catalysed ascorbate oxidation-S. Expression of MBP-PfCtr369Nt-S was targeted to the E. coli periplasm.
n a 12.5% reducing SDS-PAGE. Western blot of A. probed with either
li lysate; lane 2, periplasmic proteins; lanes 3–5 represent
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Figure 3 MBP-PfCtr369Nt-S binds copper in vitro and within E. coli host cells. A. Affinity-purified MBP-PfCtr369Nt-S or MBP was incubated
with CuCl2 in the presence (+) or absence (−) of ascorbic acid in vitro. The BCA release assay detected copper with (solid bars) or without (open
bars) the addition of ascorbic acid. The concentration of the copper standard (CuCl2 only) was equimolar to the amount of protein used. B. CuCl2
was added to the E. coli cell growth medium after the induction of recombinant protein expression. Following affinity purification, protein-bound
copper was detected using the BCA release assay with (solid bars) or without (open bars) the addition of ascorbic acid. The addition of copper to
the E. coli growth medium increased recombinant protein yield (inset). In all panels, MBP serves as a control and * represents statistical
significance (p < 0.05). Results are means ± S.D. of triplicate measurements done for duplicate dialysis sacs.
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255 nm of a 120 μM ascorbate solution at pH 4.5. This
pH was optimal for several reasons. First, increased con-
centrations of the ascorbate monoanion (HAsc-), which
has a pKa of 4.1, cause increased oxidation rates thus ele-
vated pH values can amplify unwanted errors. Second,
Cu2+ hydrolysis is minimal at a lower pH [36]. Last, and
perhaps more relevant to the amino terminal domain of
the putative P. falciparum copper transporter, is that the
related human Ctr1 shows increased copper uptake at a




Figure 4 MBP-PfCtr369Nt-S inhibits the copper-catalysed oxidative de
exposed to air (indicated by the light gray circle). The addition of CuCl2 cat
gray diamond), with this oxidation rate reduced by the inclusion of MBP-Pf
dark gray square) did not prevent the copper-catalysed oxidation of ascorbtheir media to pH 4 – 5 [37]. Freshly prepared ascorbate
showed a stable absorbance at 255 nm (A255) over 300 se-
conds (Figure 4). The addition of 8 μM CuCl2 caused a
rapid decrease in the A255 signal, indicative of oxidation
by copper. The copper-catalysed oxidation appeared to
be inhibited by the addition of 5 μM purified MBP-
PfCtr369Nt-S (Figure 4). This suggested MBP-PfCtr369Nt-S
chelates copper in solution, thus preventing its participa-
tion in the redox cycle of ascorbate oxidation. Although
this assay is not definitive of the copper species preferen-
tially bound by MBP-PfCtr369Nt-S, it is presumably Cu+,e (sec) 
gradation of ascorbate. Ascorbate does not auto-oxidize when
alyses the oxidation of the ascorbate solution (indicated by the dark
Ctr369Nt-S (indicated by the light gray triangle). MBP (indicated by the
ate.
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conducted for MBP-PfCtr369Nt-S (Figure 3). Control
experiments indicated MBP had minimal influence on the
copper-catalysed oxidation rate of ascorbate.Native expression of a putative P. falciparum copper
transport protein
An antibody probe specific for the putative P. falciparum
copper transporter (PF14_0369) was designed to detect
the native P. falciparum protein. Parasite lysates from
sorbitol-synchronized P. falciparum parasite cultures
were separated by SDS-PAGE (Figure 5A) and trans-
ferred to a nitrocellulose membrane. Affinity purified
anti-peptide antibodies targeting the N-terminal do-
main of the putative P. falciparum copper transporter
recognized protein bands of 34 kDa and 68 kDa in most
stages of sorbitol-synchronized, asexual cultured para-
sites (Figure 5C). These bands may represent mono-
meric and dimeric species, as has been suggested for
human Ctr1 [37]. Expression of the putative copper
transporter appeared to increase in a similar manner to
Pf. LDH as P. falciparum progressed through its asexual
cycle (Figure 5B). The increase in protein expression
is also seen as an increase in PF14_0369 transcrip-
tion [38].Figure 5 Expression of the putative P. falciparum copper transporter
falciparum parasites were grown in vitro, synchronized by sorbitol treatmen
1 x 107 synchronous, saponin-isolated P. falciparum parasites were analysed
probed with chicken anti-LDH peptide antibodies B. and anti-PF14_0369 p
late rings/early trophozoites; lane 3 (L3), trophozoites; lane 4 (L4), late troph
of asexual development are shown below panel A (L1 – L5). M are the preLocalization of a putative P. falciparum copper transport
protein
Characterized copper transport proteins are defined as
integral membrane proteins that, depending on cell type,
localize to either the plasma membrane or intracellular
vesicles [8]. Analysis of the PF14_0369 protein sequence
predicted an amino terminal signal peptide [39] and an
apicoplast targeting signal [40]. Further analysis indi-
cated that PF14_0369 lacked an identifiable PEXEL/HT
motif. This suggested the putative copper transporter
would be targeted to the parasite’s apicoplast and not to
the parasite or erythrocyte plasma membranes. To de-
fine the protein’s native sub-cellular location, the anti-
peptide antibodies specific for the putative copper
transporter were used in immunofluorescence assays.
For this assay a modified form of the fixation protocol
developed by Tonkin et al. [27] was employed. Advan-
tages of this technique, over the traditional methanol or
methanol/acetone fixation methods, include decreased
auto-fluorescence and improved preservation of cell
morphology [27].
Sorbitol-synchronized parasites at various develop-
mental stages were fixed as described above and probed
with specific anti-peptide antibodies. In ring stage para-
sites, the majority of the fluorescence signal could be
detected in close proximity to the erythrocyte plasma(PF14_0369) in synchronized asexual parasites. Asexual P.
t and samples removed at five time points. Equivalent amounts of
by A. 12.5% reducing SDS-PAGE, blotted onto nitrocellulose and
eptide antibodies C. In all panels: lane 1 (L1), early rings; lane 2 (L2),
ozoites; lane 5 (L5), schizonts. Representative images of each stage
stained molecular marker proteins.
Figure 6 Immunolocalization of a putative P. falciparum copper transport protein. Asexual P. falciparum parasites were grown in vitro,
synchronized by sorbitol treatment and samples removed at five time points (A – E). Fixed parasites were probed with chicken anti-peptide
antibodies targeting PF14_0369 and rabbit antibodies against Exp-1. Chicken antibodies were detected with a Cy3-conjugated antibody and
rabbit antibodies with a Cy2-conjugated antibody. Panels are representative of the following stages of asexual parasite development: A. early
rings; B. late rings; C. early trophozoites; D. late trophozoites; E. schizonts. Parasite DNA was stained with Hoechst. Scale bar is 5 μm.
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found close to the body of the parasite. The signal asso-
ciated with the parasite body overlaps considerably with
that for Exp-1, a marker of the parasitophorous vacuole
membrane [41]. As parasites progressed through the
erythrocytic cycle, the erythrocyte plasma membrane
staining became progressively weaker, with a concomi-
tant increase in the signal co-localizing with Exp-1
(Figure 6B-E). The specificity of this signal migration
becomes even more apparent in panels in which two dif-
ferent parasites of slightly different developmental pro-
gression show differing fluorescence phenotypes
(Figure 6B and C). Towards the later stages of parasite
development, the entire fluorescence signal can be seen
in tight association with the parasite itself, with no signal
detectable in the erythrocyte (Figure 6D and E). As the
copper transporter is predicted to contain apicoplast tar-
geting information, we carried out immuno-colocalization
studies using antisera detecting the apicoplast residentprotein acyl-carrier protein. Even in parasite stages in
which the copper transporter appears to localize with the
body of the parasite, no significant signal co-localization
was noted. All images were acquired using the same ex-
posure time to allow for direct comparison of signal
strength. Control experiments using pre-immune anti-
body preparations or only secondary antibodies showed
no antibody staining and additionally experiments target-
ing the P. falciparum cytoplasmic proteins LDH, GAPDH
and HSP86/90 showed a notably different localization
from that of the putative copper transporter. No signal
was seen to associate with non-infected erythrocytes
(Figure 6A-E).
Analysis of PF14_0369 for novel export signals
Export of the putative copper transporter to the erythro-
cyte surface was surprising considering the lack of an
identifiable PEXEL/HT motif. Exported P. falciparum
proteins lacking a PEXEL motif have previously been
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proteins” (PNEPs) [42]. Partial PEXEL motifs have been
identified in the amino terminal domain of the PNEPs
REX2 (LAE) [43] and SBP1 (LAD) [44] that are essential
for export. Inspection of the PF14_0369 amino terminal
domain identified a partial PEXEL motif identical to the
important LAD motif identified in SBP1. Analysis of the
essential transmembrane domains from SBP1 and REX2
highlighted a relative abundance of phenylalanine resi-
dues [43] also found in the third transmembrane domain
of PF14_0369 (Additional file 1).
Discussion
Maintenance of copper homeostasis is essential for cell
survival. Consequently sophisticated mechanisms have
evolved for copper acquisition, distribution and excre-
tion. In mammalian cells, copper is acquired by the cop-
per transport protein Ctr1 and distributed to target
proteins via dedicated copper metallochaperones such as
CCS, Atox1 and Cox17 [7,8]. To avoid the potentially
toxic effects of copper, Cu-ATPase proteins mediate the
excretion of excess copper [9] and a P. falciparum Cu-
ATPase ortholog has been identified [5]. One P. falcip-
arum copper source appears to be from the ingestion of
host erythrocyte Cu/Zn SOD [5]. A screen of the Plas-
moDB database, performed in the present study, identi-
fied six P. falciparum copper-requiring protein orthologs
and a candidate copper transport protein. Native expres-
sion of the putative copper transporter was confirmed
by Western blot and the protein’s subcellular location
identified by immunofluorescence microscopy. A recom-
binant form of the transporter's amino terminal domain
was shown to bind copper in vitro and within E. coli
host cells, supporting the possibility that the full-length
protein functions to acquire copper.
Identification of a putative P. falciparum copper transport
protein
The identification of six P. falciparum copper-requiring
protein orthologs suggested an important role for copper
in P. falciparum metabolism. Treating P. falciparum
parasites with the intracellular copper chelator, neocu-
proine, inhibited ring-to-trophozoite transition in vitro
[5], highlighting the importance of copper for the para-
site. During the course of its asexual cycle, P. falciparum
appears to digest host erythrocyte Cu/Zn SOD to release
copper [5]. The presence of a membrane associated cop-
per binding protein with copper transport protein char-
acteristics in plasmodia suggests a mechanism for the
transport of copper similar to that played by the Ctr1
copper transport protein in yeast and mammalian cells
[7,8]. Candidate copper transporter sequences were
identified for eight species of the Plasmodium parasite
and each sequence was shown to contain the essentialand largely definitive Mx3M and Gx3G motifs
(Figure 1B) [30,45]. The predicted amino terminal do-
main of each putative transporter was found to contain
one or more methionine motifs (MxM or MxxM). Al-
though not limited to copper transporters, these motifs
are important for Ctr1 protein function [30].
The presence of three putative membrane-spanning
regions is considered definitive for copper transport
proteins [33] and topological analysis of the putative
P. falciparum copper transporter identified three such
domains. Since three transmembrane domains cannot
form a functional channel or pore for ion transport [10], a
homotrimeric complex of copper transport protein mono-
mers is formed for the characterized mammalian and
yeast copper transport proteins [33]. The P. falciparum
copper transport protein may form a similar complex
since the first transmembrane domain of the copper trans-
port protein family serves as an adaptor allowing evolu-
tionarily distant copper transporters to adopt a similar
overall structure [46]. An immunoblot of yeast and
mammalian copper transport proteins identified mono-
meric and dimeric species of the trimeric complex [37].
Similar monomeric and dimeric species were detected
in an immunoblot of the putative P. falciparum copper
transport protein in this study.
Recombinant expression and copper binding to
MBP-PfCtr369Nt-S
Signal peptides, transmembrane domains, rare codons,
introns and genome AT-richness affect recombinant
expression of P. falciparum proteins [34]. The amino
terminal signal peptide of the putative P. falciparum
copper transporter was, therefore, excluded from the
expression construct, resulting in periplasmic expression.
The purified MBP-PfCtr369Nt-S recombinant protein
bound reduced copper in vitro and within a cellular
environment. A second copper transport protein, MBP-
PfCtr211Nt-S, from the PF14_0211 gene was recombi-
nantly expressed and isolated. Expression of the native
P. falciparum protein encoded by this gene has not
been ascertained at this stage.
In mammalian and yeast cells, the reduced cuprous
ion (Cu+) is favoured for transfer and transport [30],
since Cu+ is more exchange labile than Cu2+ [36]. Cu+ is
highly reactive in an oxidizing environment and methio-
nine motifs in the extracellular amino terminal domain
of the copper transporter family are thought to sequester
copper prior to its transport across the lipid bilayer [30].
This was supported by a study demonstrating that
methionine motif peptides inhibited copper-catalysed
ascorbate oxidation through Cu+ chelation [36]. MBP-
PfCtr369Nt-S inhibited copper-catalysed ascorbate oxi-
dation through copper chelation. Taken together with
the data showing copper binding to MBP-PfCtr369Nt-S,
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putative P. falciparum copper transporter preferably
coordinates the Cu+ ion. Copper coordination was
presumably a result of the methionine motif present
in MBP-PfCtr369Nt-S.
The methionine motifs contained in the amino terminal
domains of yeast and human copper transport proteins
are essential for copper binding under copper limiting
conditions [30]. The yeast copper transport protein con-
tains eight methionine motifs, but only the last methio-
nine of the eighth motif was shown by Puig et al. [30] to
be essential for copper binding capability. The position of
this methionine is conserved between copper transport
proteins and is 20 amino acid residues N-terminal to the
transporter’s first transmembrane domain [30]. Interest-
ingly, the last methionine of the methionine motif in the
amino terminal domain of the putative P. falciparum
copper transport protein is located in a similar position.
However, the involvement of other amino acid residues,
like cysteine and histidine residues that bind metal ions
[47,48], and are present in this protein cannot be
excluded. Identification of the specific residues coordi-
nating copper will be explored in future experiments.
MBP-PfCtr369Nt-S recombinant protein likely interacts
with E. coli copper binding proteins
An interesting consequence of expressing MBP-
PfCtr369Nt-S in the presence of copper was a significant
increase in recombinant protein yield. In the presence of
excess copper it is a possibility that the copper bound to
and stabilized the recombinant protein [48]. The cyto-
plasm and periplasm of E. coli cells do, however, have
different copper requirements since almost all bacterial
copper proteins, such as multi-copper oxidases, amine
oxidases and lysine oxidases are found in the periplasm
or excreted extracellularly [49]. Copper availability in E.
coli is thought to be regulated by the actions of the
DNA-binding metal sensor CueR, which controls the ex-
pression of genes encoding proteins involved in metal
homeostasis [50]. A copper-requiring protein is thought
to gain access to copper only if the protein’s affinity for
the metal ion is greater than the buffered cellular con-
centration of copper [51]. Interaction of a recombinant
P. falciparum protein with native E. coli proteins has
been demonstrated for PfHsp70 [52], supporting the
possibility that MBP-PfCtr369Nt-S interacts with native
E. coli copper proteins for copper loading. These interac-
tions could, in turn, influence the availability of copper
for native E. coli copper-requiring proteins resulting in
tightly regulated MBP-PfCtr369Nt-S expression under
standard growth conditions. The addition of excess
extracellular copper appears to have alleviated this
growth stress producing the increase in the expression
of MBP-PfCtr369Nt-S observed here.The putative P. falciparum copper transport protein
shows stage-specific localization
During early stages of asexual development, the putative
P. falciparum copper transporter appears to be targeted
to the plasma membrane of the infected erythrocyte. As
the parasite matures through its asexual cycle the pro-
tein was detected on a parasite membrane. This may
represent a turnover of host cell membrane associated
malarial proteins, followed by trafficking of the copper
transporter to a parasite membrane. The precise
localization of the copper transporter, when associated
with the parasite, was not elucidated, due to limits to
the fluorescence detection methods. The parasitopho-
rous vacuolar membrane contains a “promiscuous” pore
that permits the passage of solutes, nutrients and macro-
molecules [53,54] and thus it is unlikely for there to be
the need for a separate copper transporter. The parasite
plasma membrane contains a variety of selective trans-
porters (Reviewed by Martin et al. [4]). The copper
transporter is thus suggested to be associated with the
parasite plasma membrane. PfCuP-ATPase was similarly
localized to a parasite plasma membrane and the surface
of the infected erythrocyte. However, unlike the putative
copper transport protein, PfCuP-ATPase was associated
with both the parasite plasma membrane and the
erythrocyte membrane at the same time in trophozoites
and schizonts, whilst no expression was detected in rings
[5]. These authors suggested that dual localization of
PfCuP-ATPase represents a novel mechanism by which
the parasite reduces copper toxicity through copper ef-
flux [5]. Reasons for the different localities of the copper
transport protein are less apparent. There is the possibi-
lity that during ring stages, extracellular copper is
required until the parasite digests endocytosed host cell
Cu/Zn SOD and translocates the copper transporter
protein to a parasite membrane.
The concentration of copper in normal red blood cells
has been reported as18 μM and copper is imported into
red cells by a Cl--HCO3
- anion exchanger [55]. Inside the
red cell most of the copper is associated with Cu/Zn
SOD and a 30 and a 40 kDa red cell protein [56]. Raso-
loson et al. [5] reported a lower red cell copper concen-
tration at 10 μM and further suggested that copper
concentrations in parasitized cells was lower than unin-
fected cells. Copper in isolated parasites was lower than
in red cells at 2 μM in rings and between 6 and 6.6 μM
in trophozoites (depending on the isolation method).
This data disagrees with recent data indicating that mal-
aria infected red cell copper concentration was 30 μM,
and double that of uninfected red cells in the same ex-
periment [57]. The different values for copper concen-
trations in infected red cells may be due to the different
measuring methods employed and needs to be recon-
ciled [5,57]. Interestingly as the parasite develops from
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Cu/Zn SOD decreases [5] and this coincides with data
presented here showing the appearance of the putative
copper transporter on parasite membranes, the highest
level of expression of the protein, and mRNA levels
described by Le Roch et al. [38]. Thus as the source of
copper in the form of Cu/Zn SOD decreases in the para-
site [5], the parasite compensates with an increase in ex-
pression of the putative copper transport protein. Given
the potential toxicity of copper and the need for the
regulation of copper homeostasis, it is likely that the
parasite employs a copper transport protein alongside
the PfCuP-ATPase copper export protein described by
Rasoloson et al. [5]. It is suggested that, given the pres-
ence and membrane location of a copper binding protein
with copper transporting motifs, and the increase in
copper concentration in malaria infected red cells [57],
that the protein described here has a role in copper
transport. Data to support a transport role for the cop-
per binding protein is being pursued.
Treatment of P. falciparum parasites with neocuproine
inhibited ring-to-trophozoite transition [5], implicating
copper metabolism as a potential target for novel anti-
malarial drug development. Copper, when the concen-
tration is above a critical level, has been shown to be
toxic to the parasite [58]. However, from in silico find-
ings it seems unlikely that P. falciparum contains unique
copper-dependent metabolic pathways. Copper-binding
protein motifs also appear to be conserved from prokar-
yotes to eukaryotes [59], suggesting that designing a
compound specific for P. falciparum copper-dependent
proteins could prove difficult. An alternative approach
would be to deliver anti-malarial compounds to the
parasite by exploiting transport mechanisms, as sug-
gested for the P. falciparum new permeation pathway
and choline carrier [60]. The human copper transport
protein has been shown to transport the platinum con-
taining anti-cancer drugs cisplatin and oxaliplatin [61].
Cisplatin also exhibits anti-malarial activity through
DNA damage [62,63]. Given the structural similarities
between the putative P. falciparum copper transport
protein and the human copper transporter, it is possible
that cisplatin is delivered to the parasite by the putative
copper transport protein. This transport mechanism
could perhaps be exploited for the delivery of novel
platinum-based anti-malarial compounds.
Plasmodium falciparum actively remodels the erythro-
cyte during infection, leading to an increase in the per-
meability of the host cell membrane to low molecular
weight solutes [64]. This increase is mediated by ‘new
permeability pathways’ that have also been shown to
greatly facilitate the uptake of the antibiotics fosmido-
mycin and its derivative FR900098 [62]. Parasitized ery-
throcytes also show a significant increase in the uptakeof a copper-neocuproine complex when compared to
uninfected erythrocytes [65]. Association of the putative
P. falciparum copper transport protein with the erythro-
cyte membrane, during early asexual development,
therefore makes it tempting to speculate that the copper
transport protein’s mechanism accounts for the increased
rate of copper-neocuproine complex uptake by parasitized
erythrocytes. Complexation of the anti-malarial buparva-
quone to copper(II) significantly enhanced its anti-
malarial activity [66]. This was proposed to be a conse-
quence of improved compound internalisation, which may
be related to the transport mechanism of the putative cop-
per transport protein. Localization of the P. falciparum
copper transport protein to the erythrocyte and parasite
membranes in late ring and early trophozoite stages may
explain the increased susceptibility of these stages to cis-
platin [67].
The putative copper transport protein sequence lacks an
identifiable export motif
Plasmodium falciparum protein export beyond the para-
sitophorous vacuole membrane was suggested to be
mediated by the PEXEL/HT motif, but this motif was
later shown not to be the sole determinant of protein ex-
port. Over 300 PEXEL/HT proteins have been predicted,
whereas only a few PEXEL negative export proteins
(PNEPs) have been identified and a common PNEP
motif is yet to be identified [68]. One important feature
of PNEP proteins is the presence of a transmembrane
domain, since removal of this domain from the PNEPs
MAHRP1, SBP1 and REX2 inhibited protein export
[43,44]. Similarly, the transmembrane domain of SUR-
FIN4.2 was essential for protein trafficking to the infected
erythrocyte and Maurer’s clefts [69].
Analysis of the PNEPs REX2 [43] and SBP1 [44] iden-
tified partial PEXEL/HT motifs (LAE and LAD, respect-
ively) as being essential for protein export. Analysis of
the PF14_0369 sequence identified an identical LAD
motif within the first 20 amino acids of its amino ter-
minal domain, a similar position to the LAD motif in
SBP1. Mutational analysis of the related LAE motif in
REX2 established that the glutamate residue was essen-
tial for export [43]. This suggests the related aspartate
residue in the LAD motif of PF14_0369 may be import-
ant for export. Cleavage of the signal peptide in the
PF14_0369 sequence would generate a new amino
terminus similar to that generated following cleavage of
the PEXEL motif in PEXEL/HT proteins. PEXEL motif
cleavage generates an xD/E/Q amino terminus, with the
presence of D/E/Q being essential for protein export
[70]. Another potential export signal in SBP1 is located
N-terminal of its transmembrane domain, between
amino acids 180 and 190 [44]. A comparison of this
short signal sequence (NEYEVES) with the PF14_0369
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first predicted transmembrane domain (NKWETKS),
thereby implicating this sequence as a potential con-
tributor to successful protein export. The presence of
motifs in PF14_0369 similar to those important for
PNEP export suggests that these motifs play a role in
the export of the putative copper transporter.
The amino terminal domain of the P. falciparum cop-
per binding protein described here binds copper in vitro
and in an in vivo expression system. The protein has cop-
per transport motifs and has been shown to be expressed
by malaria parasites and locate to two different mem-
branes (the erythrocyte and the parasite membrane) as
the parasite develops within the infected red cell. This
evidence implicates a copper transport role for the pro-
tein in malaria infected erythrocytes and this implication
is being explored. Whether the protein imports copper
or has a copper export role alongside the Cu-ATPase
protein described by others [5], remains to be elucidated.
Conclusions
A putative P. falciparum copper transport protein was
identified and showed that the recombinant amino ter-
minal domain binds copper in vitro and within E. coli
host cells. This ability, combined with conserved copper
transport protein sequence features, suggest an additional
malaria copper transport mechanism to that previously
described [5]. Interestingly, the putative P. falciparum
copper transport protein initially localized to the erythro-
cyte membrane and then relocated to a parasite mem-
brane through the course of asexual development. The
presence of a putative malaria copper transport protein
has interesting implications for malaria copper metabo-
lism and the protein may have a potential role as a novel
anti-malarial drug delivery system.
Additional files
Additional file 1: Important features of the PF14_0369 amino acid
sequence. Important features of the PF14_0369 amino acid sequence
include a predicted N-terminal signal peptide (underlined), three
transmembrane domains (black boxes and numbered 1,2,3), an essential
methionine residue M, 20 amino acids N-terminal of the first
transmembrane domain, and the MX3M and GX3G motifs. Features
thought to contribute to protein trafficking include a partial PEXEL motif
(LAD) in the signal peptide and an enrichment of phenylalanine residues
(F) in the third transmembrane domain.
Additional file 2: Expression and purification of recombinant MBP-
PfCtr211Nt-S. Expression of MBP-PfCtr211Nt-S was targeted to the E. coli
periplasm. Steps in the isolation of recombinant MBP-PfCtr211Nt-S were
analysed on a 10% reducing SDS-PAGE. Lane 1 and 2, total E. coli lysate;
lane 3, periplasmic proteins; lane 4 represents proteins that did not bind
and lanes 5–10 show protein eluted off the amylose resin. Fermentas
unstained protein marker standards are shown to the left of each image.
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